共有 50 笔近期内部人交易记录记录，涉及 Tactile Systems Technology, Inc. (TCMD), 包括 26 笔买入 和 21 笔卖出. 内部人买入总额为 RSU 奖励 内部人卖出总额为 $2M.
近期活跃的重要内部人包括 Pearson Andrea, Dodd Sheri Louise, Burns Kristie. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — TCMD
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2026-03-09 |
Pearson Andrea |
Officer |
未知 |
- |
- |
- |
- |
| 2026-03-09 |
Pearson Andrea |
Director |
限制性股票授予 (RSU) |
852 |
- |
- |
852 |
| 2026-02-24 |
Dodd Sheri Louise |
Chief Executive Officer |
知情卖出 |
10,993 |
$28.94 |
$318.14K |
243,885 |
| 2026-02-24 |
Burns Kristie |
Sr. VP Mktg & Clinical Affairs |
知情卖出 |
6,246 |
$28.94 |
$180.76K |
82,581 |
| 2026-02-24 |
Birkemeyer Elaine M. |
Chief Financial Officer |
知情卖出 |
7,701 |
$28.94 |
$222.88K |
134,819 |
| 2026-02-23 |
Dodd Sheri Louise |
Chief Executive Officer |
知情卖出 |
537 |
$28.69 |
$15.41K |
254,878 |
| 2026-02-23 |
Burns Kristie |
Sr. VP Mktg & Clinical Affairs |
知情卖出 |
160 |
$28.69 |
$4.59K |
88,827 |
| 2026-02-23 |
Birkemeyer Elaine M. |
Chief Financial Officer |
知情卖出 |
196 |
$28.69 |
$5.62K |
142,520 |
| 2026-02-20 |
Dodd Sheri Louise |
Chief Executive Officer |
限制性股票授予 (RSU) |
19,751 |
- |
- |
241,902 |
| 2026-02-20 |
Burns Kristie |
Sr. VP Mktg & Clinical Affairs |
限制性股票授予 (RSU) |
3,490 |
- |
- |
82,085 |
| 2026-02-20 |
Birkemeyer Elaine M. |
Chief Financial Officer |
限制性股票授予 (RSU) |
3,579 |
- |
- |
125,698 |
| 2026-02-19 |
Dodd Sheri Louise |
Chief Executive Officer |
限制性股票授予 (RSU) |
48,672 |
- |
- |
222,151 |
| 2026-02-19 |
Burns Kristie |
Sr. VP Mktg & Clinical Affairs |
限制性股票授予 (RSU) |
6,194 |
- |
- |
78,595 |
| 2026-02-19 |
Birkemeyer Elaine M. |
Chief Financial Officer |
限制性股票授予 (RSU) |
23,008 |
- |
- |
122,119 |
| 2026-01-02 |
Burns Kristie |
Sr. VP Mktg & Clinical Affairs |
知情卖出 |
5,139 |
$28.85 |
$148.26K |
72,401 |
| 2025-08-08 |
Dodd Sheri Louise |
Chief Executive Officer |
知情卖出 |
7,762 |
$12.36 |
$95.91K |
173,479 |
| 2025-05-12 |
Birkemeyer Elaine M. |
Chief Financial Officer |
知情卖出 |
2,921 |
$9.94 |
$29.04K |
99,111 |
| 2025-05-08 |
Burke William W |
Director |
知情卖出 |
3,300 |
$9.67 |
$31.91K |
48,520 |
| 2025-05-08 |
Dodd Sheri Louise |
Chief Executive Officer |
知情卖出 |
3,149 |
$9.83 |
$30.95K |
181,241 |
| 2025-05-07 |
Burke William W |
Director |
限制性股票授予 (RSU) |
16,078 |
- |
- |
51,820 |
| 2025-05-07 |
Volkart Carmen B |
Director |
限制性股票授予 (RSU) |
16,078 |
- |
- |
37,698 |
| 2025-05-07 |
Huggenberger Raymond |
Director |
限制性股票授予 (RSU) |
16,078 |
- |
- |
56,320 |
| 2025-05-07 |
Shafer David Brent |
Director |
限制性股票授予 (RSU) |
16,078 |
- |
- |
48,822 |
| 2025-05-07 |
Asbury Valerie L. |
Director |
限制性股票授予 (RSU) |
16,078 |
- |
- |
48,822 |
| 2025-05-07 |
Washington Boyd Vindell |
Director |
限制性股票授予 (RSU) |
16,078 |
- |
- |
35,247 |
| 2025-05-07 |
King Laura G. |
Director |
限制性股票授予 (RSU) |
16,078 |
- |
- |
19,048 |
| 2025-03-11 |
Reuvers Daniel L. |
Director |
赠与（收到） |
68,162 |
- |
- |
68,162 |
| 2025-02-25 |
Reuvers Daniel L. |
Director |
知情卖出 |
28,338 |
$14.18 |
$401.85K |
214,604 |
| 2025-02-25 |
Burns Kristie |
Sr. VP Mktg & Clinical Affairs |
知情卖出 |
6,468 |
$14.40 |
$93.16K |
77,540 |
| 2025-02-25 |
Birkemeyer Elaine M. |
Chief Financial Officer |
知情卖出 |
2,066 |
$14.51 |
$29.98K |
102,032 |
| 2025-02-24 |
Reuvers Daniel L. |
Director |
知情卖出 |
10,938 |
$14.55 |
$159.15K |
242,942 |
| 2025-02-24 |
Burns Kristie |
Sr. VP Mktg & Clinical Affairs |
知情卖出 |
4,830 |
$14.65 |
$70.75K |
84,008 |
| 2025-02-24 |
Birkemeyer Elaine M. |
Chief Financial Officer |
知情卖出 |
3,778 |
$14.70 |
$55.54K |
104,098 |
| 2025-02-20 |
Reuvers Daniel L. |
Director |
限制性股票授予 (RSU) |
15,853 |
- |
- |
253,880 |
| 2025-02-20 |
Dodd Sheri Louise |
Chief Executive Officer |
限制性股票授予 (RSU) |
20,108 |
- |
- |
118,721 |
| 2025-02-20 |
Burns Kristie |
Sr. VP Mktg & Clinical Affairs |
限制性股票授予 (RSU) |
3,359 |
- |
- |
68,128 |
| 2025-02-20 |
Birkemeyer Elaine M. |
Chief Financial Officer |
限制性股票授予 (RSU) |
3,446 |
- |
- |
64,741 |
| 2025-02-20 |
King Laura G. |
Director |
限制性股票授予 (RSU) |
2,970 |
- |
- |
2,970 |
| 2025-01-13 |
King Laura G. |
Director |
未知 |
- |
- |
- |
- |
| 2024-08-12 |
Ferstler Sherri Lee |
Senior VP, Sales |
知情卖出 |
1,550 |
$13.07 |
$20.26K |
38,764 |
| 2024-08-07 |
Dodd Sheri Louise |
Chief Executive Officer |
限制性股票授予 (RSU) |
64,959 |
- |
- |
98,613 |
| 2024-05-16 |
Birkemeyer Elaine M. |
Chief Financial Officer |
知情卖出 |
3,041 |
$13.68 |
$41.59K |
61,295 |
| 2024-05-08 |
Burke William W |
Director |
知情卖出 |
2,500 |
$14.06 |
$35.15K |
25,273 |
| 2024-05-08 |
Volkart Carmen B |
Director |
限制性股票授予 (RSU) |
10,469 |
- |
- |
21,620 |
| 2024-05-08 |
Huggenberger Raymond |
Director |
限制性股票授予 (RSU) |
10,469 |
- |
- |
40,242 |
| 2024-05-08 |
Shafer David Brent |
Director |
限制性股票授予 (RSU) |
10,469 |
- |
- |
32,744 |
| 2024-05-08 |
Dodd Sheri Louise |
Director |
限制性股票授予 (RSU) |
10,469 |
- |
- |
33,654 |
| 2024-05-08 |
Asbury Valerie L. |
Director |
限制性股票授予 (RSU) |
10,469 |
- |
- |
32,744 |
| 2024-05-08 |
Washington Boyd Vindell |
Director |
限制性股票授予 (RSU) |
10,469 |
- |
- |
19,169 |
| 2024-05-06 |
Burns Kristie |
Sr. VP Mktg & Clinical Affairs |
知情卖出 |
815 |
$14.37 |
$11.71K |
62,574 |
■ 知情交易 — 公开市场买卖（最具参考价值）
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期
